Basking Ridge, NJ1 Active Studies

Neuroendocrine Tumors Clinical Trials in Basking Ridge, NJ

Find 1 actively recruiting neuroendocrine tumors clinical trials in Basking Ridge, NJ. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
806
Enrolling

Recruiting Neuroendocrine Tumors Studies in Basking Ridge

About Neuroendocrine Tumors Clinical Trials in Basking Ridge

Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.

There are currently 1 neuroendocrine tumors clinical trials recruiting participants in Basking Ridge, NJ. These studies are seeking a combined 806 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Neuroendocrine Tumors Clinical Trials in Basking Ridge — FAQ

Are there neuroendocrine tumors clinical trials in Basking Ridge?

Yes, there are 1 neuroendocrine tumors clinical trials currently recruiting in Basking Ridge, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Basking Ridge?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Basking Ridge research site will contact you about next steps.

Are clinical trials in Basking Ridge free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Basking Ridge studies also compensate for your time and travel.

What neuroendocrine tumors treatments are being tested?

The 1 active trials in Basking Ridge are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.

Data updated July 13, 2026 from ClinicalTrials.gov